scispace - formally typeset
Y

Yu-He Yuan

Researcher at Peking Union Medical College

Publications -  90
Citations -  2747

Yu-He Yuan is an academic researcher from Peking Union Medical College. The author has contributed to research in topics: Neuroprotection & Phosphorylation. The author has an hindex of 28, co-authored 83 publications receiving 2045 citations.

Papers
More filters
Journal ArticleDOI

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.

TL;DR: Some inhibitors of NLRP3 inflammatory pathways are focused on to alleviate the progression of PD by inhibiting central inflammation and provide new therapeutic strategies for the treatment of PD.
Journal ArticleDOI

Gap Junction Dysfunction in the Prefrontal Cortex Induces Depressive-Like Behaviors in Rats

TL;DR: The results demonstrate that carbenoxolone infusions induced anhedonia in SPT, and anxiety in NSFT, and Cx43 mimetic peptides Gap27 and Gap26 also induced a core symptom of depression.
Journal ArticleDOI

Lycojaponicumins A-C, three alkaloids with an unprecedented skeleton from Lycopodium japonicum.

TL;DR: Lycojaponicumins A-C (1-3), three trace alkaloids isolated from Lycopodium japonicum, represent a unique heterocyclic skeleton formed by the new linkage C4-C9, and are the first examples of natural products possessing a 5/5/5 /5/6 pentacyclic ring system with a 1-aza-7-oxabicyclo[2.2.1]heptane moiety.
Journal ArticleDOI

Pathological α-synuclein exacerbates the progression of Parkinson's disease through microglial activation.

TL;DR: This review will mainly describe the profiles of α-synuclein-activated microglia, with particular emphasis on the signaling cascades involved in this process.
Journal ArticleDOI

2-(2-phenylethyl)chromones from Chinese eaglewood.

TL;DR: One chromone showed significant neuroprotective activities against both glutamate-induced and corticosterone-induced neurotoxicity in P12 pheochromocytoma and human U251 glioma cells at a concentration of 10 μM and increased cell viability by 82.2% and 86.9%, respectively.